US drug and biologic approvals in 1998
Bert Spilker, Stacey R. Fitzsimmons, Michael J. Horan
Abstract
Bert Spilker, Stacey R. Fitzsimmons, Michael J. Horan
Abstract
The Prescription Drug User Fee Act of 1992 enhanced review resources for the Food and Drug Administration (FDA). The past 3 years have seen an unprecedented approval of 122 new drugs and 28 new biologics. Information is provided on the 39 new products approved by the FDA in 1998. Drug Dev. Res. 48:139–153, 1999. © 1999 Wiley-Liss, Inc.
OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The Prescription Drug User Fee Act of 1992 enhanced review resources for the Food and Drug Administration (FDA). The past 3 years have seen an unprecedented approval of 122 new drugs and 28 new biologics. Information is provided on the 39 new products approved by the FDA in 1998. Drug Dev. Res. 48:139–153, 1999. © 1999 Wiley-Liss, Inc.
Key concepts: Food and drug administration, Drug, Drug approval, Medicine, Pharmacology, Medical prescription, New drug application, Prescription drug